US teenager crafts early detection tool for cancer

February 28, 2013 by Glenn Chapman
Jack Andraka speaks after receiving Smithsonian Magazine's first annual American Ingenuity Award for youth achievement on November 28, 2012 in Washington, DC. Andraka catapulted from being a typical US teenager unaware of the pancreas to one with a cheap way to detect cancer in the organ before it turns deadly.

Jack Andraka catapulted from being a typical US teenager unaware of the pancreas to one with a cheap way to detect cancer in the organ before it turns deadly.

"Through the Internet, anything is possible," Andraka said while telling the story of his screening breakthrough at a prestigious in Southern California on Wednesday.

"There is so much more to it than posting duck-face pictures of yourself online," he continued, sucking in his cheeks and pushing out his lips to playfully underscore his point.

"If a 15-year-old who didn't know what a was could figure out a way to detect , imagine what you could do."

Andraka, who turned 16 in January, recounted how three years ago he began scouring the Internet for information about pancreatic cancer after it killed a cherished family friend.

He told of being shocked to learn that the cancer was typically found too late to save people. On top of that, the test used to screen for the illness was 60 years old, he said.

"That is older than my dad," Andraka quipped. "More important, it is expensive, inaccurate, and your doctor would have to be ridiculously suspicious that you had the cancer to give you this test."

He figured what was needed was a test that was inexpensive, fast, simple and sensitive.

"Undeterred due to my teenage optimism, I went online to a teenager's two best friends: and ," Andraka said.

What he found was there were thousands of proteins that could be detected in the blood of people with pancreatic cancer, and he hunted for one that could serve as an early flag for the illness.

"Finally, on the 4,000th try when I am losing my sanity, I found the ," Andraka said.

The revelation came in what he described as an unlikely place, a high school he referred to as an "absolute stifler of innovation."

"I was sneakily reading this nanotubes article under my desk while we were supposed to be to ," Andraka recalled.

"Suddenly it hit me that I could combine what I was reading with what I was supposed to be thinking about."

He described a recipe for making paper sensors to detect the protein - mesothelin - in blood that is "about as simple as making chocolate chip cookies, which I love."

The test costs three cents, takes minutes, and appears to be 100 percent accurate, according to his TED Talk.

Andraka said he sent out 200 requests to scientists for lab space to continue his work, only to be rejected by all but Johns Hopkins University where he was fiercely grilled before being taken in.

He commenced to fix holes he discovered in his "once brilliant procedure" and went on to be awarded the 2012 Intel International Science and Engineering Fair grand prize.

Andraka described his approach as having the potential to be tailored to screen for other forms of cancer as well as heart disease or HIV/AIDS.

He told of currently working on "something the size of a cube of sugar" that could "look through your skin" and study blood or signs of almost any disease. The cost? An estimated five dollars.

Explore further: Researchers ID promising pancreatic cancer screening marker

Related Stories

Researchers ID promising pancreatic cancer screening marker

April 27, 2011
Researchers at the University of Michigan Comprehensive Cancer Center have identified a protein that shows distinct changes in structure between pancreatic cancer, non-cancerous diseases and normal blood serum. The protein ...

Mayo Clinic reports new findings on noninvasive test for pancreatic cancer

May 11, 2011
Pancreatic cancer has one of the highest mortality rates of any of the major cancers, and of the 43,000-plus Americans diagnosed with the disease each year, more than 94 percent die within five years of diagnosis. One reason ...

Gene linked to pancreatic cancer growth, study finds

January 31, 2012
A mutant protein found in nearly all pancreatic cancers plays a role not only in the cancer's development but in its continued growth, according to a new study from University of Michigan Comprehensive Cancer Center researchers. ...

Scientists find gene that inhibits pancreas cancer spread

April 29, 2012
Scientists have identified a gene that slows the spread of pancreatic cancer tumours, paving the way for targeted treatment of one of the deadliest forms of the disease, said a paper published Sunday.

Recommended for you

Study may explain failure of retinoic acid trials against breast cancer

July 25, 2017
Estrogen-positive breast cancers are often treated with anti-estrogen therapies. But about half of these cancers contain a subpopulation of cells marked by the protein cytokeratin 5 (CK5), which resists treatment—and breast ...

Physical activity could combat fatigue, cognitive decline in cancer survivors

July 25, 2017
A new study indicates that cancer patients and survivors have a ready weapon against fatigue and "chemo brain": a brisk walk.

Breaking the genetic resistance of lung cancer and melanoma

July 25, 2017
Researchers from Monash University and the Memorial Sloan Kettering Cancer Center (MSKCC, New York) have discovered why some cancers – particularly lung cancer and melanoma – are able to quickly develop deadly resistance ...

New therapeutic approach for difficult-to-treat subtype of ovarian cancer identified

July 24, 2017
A potential new therapeutic strategy for a difficult-to-treat form of ovarian cancer has been discovered by Wistar scientists. The findings were published online in Nature Cell Biology.

Immune cells the missing ingredient in new bladder cancer treatment

July 24, 2017
New research offers a possible explanation for why a new type of cancer treatment hasn't been working as expected against bladder cancer.

Anti-cancer chemotherapeutic agent inhibits glioblastoma growth and radiation resistance

July 24, 2017
Glioblastoma is a primary brain tumor with dismal survival rates, even after treatment with surgery, chemotherapy and radiation. A small subpopulation of tumor cells—glioma stem cells—is responsible for glioblastoma's ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

Tausch
not rated yet Mar 02, 2013
Good work.
Impressive.
You will be an exception.
The industry will see to it that you remain an exception.

Give Barry Marshall a call.
Do it.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.